Five ads claiming symptoms such as low energy and lack of sex drive are linked to low testosterone levels have been banned by the UK’s advertising watchdog.
An investigation by the Advertising Standards Authority (ASA), published on Wednesday, found that advertisements exaggerated the link between low testosterone and several common symptoms, including loss of motivation and mood changes, which have many possible causes.
The ads, which include three posters and two paid Facebook ads, were created by Voy, an online health platform and prominent seller of weight loss jabs such as Mounjaro and Wegovy.
The ASA said: “While some symptoms may be more closely related to the condition, others were much less specific and should not be presented as strong indicators of low testosterone in isolation.”
It also stated that a Facebook ad claiming low testosterone affects one in four men over 30 was “misleading and not supported by the evidence Voy provided”. Voy disputed this.
“We have banned the ads and told Voy to ensure that future ads do not mislead people about the symptoms or prevalence of low testosterone,” the ASA added.
Catherine Drewett, investigations manager at the ASA, said: “People should be able to trust the health claims they see in advertising. This ruling makes clear the standards we expect from advertisers promoting health tests and services and the importance of ensuring their claims are supported by strong evidence.
In response, Voy said the language in the ads was “deliberately conditioned”, arguing that it “does not state or imply that the advertised symptoms were definitely caused by low testosterone”.
The ASA launched its investigation after receiving several public complaints.